Dorsey Wright & Associates Vericel Corp Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 20, 2020	SELL	$7.25 - $19.22 $4,618 - $12,243	-637 Closed	0 $0
Q2 2019 Jul 02, 2019	BUY	$15.01 - $18.89 $2,386 - $3,003	159 Added 33.26%	637 $12,000
Q1 2019 Apr 04, 2019	SELL	$16.23 - $20.29 $7,693 - $9,617	-474 Reduced 49.79%	478 $8,000
Q4 2018 Jan 07, 2019	BUY	$10.77 - $18.44 $10,253 - $17,554	952 New	952 $17,000

267

48.4M

91.1K

39.8K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.05B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.